Crizanlizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Crizanlizumab and local guidelines before prescribing.

P-selectin antagonist

Mechanism

P-selectin monoclonal antibody.

Uses

Sickle cell disease vaso-occlusive crisis prevention.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infusion reactions, headache, arthralgia.

Interactions

Few.

Contraindications and cautions

Hypersensitivity

Monitoring

Crisis frequency

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Monthly infusion.

More from the textbook: uses, cautions and other points
Where it is discussed in the book